In 2023, Juan P Frias and colleagues, in The Lancet, published the first phase two clinical trial of orforglipron, which investigated the use of a small-molecule oral GLP-1R agonist called orforglipron in type 2 diabetes, which can be taken at any time of the day without restrictions on food and water intake (Frias et al., 2023)
Since receptors' activation is logarithmically dependent on the input, the change required in the input levels to elicit a consecutive pulse becomes increasingly larger
Users who shake their vials to speed dissolution end up with expensive saline solution containing fragments of destroyed peptide
HMGB1 (mainly nuclear, but also mitochondrial-binding) is a late mediator of inflammation that is elevated post-surgery and contributes to organ dysfunction
10.1002/mrm.22086 55
Beyond his onstage accomplishments, Creel was an advocate for marriage equality and co-founded Broadway Impact, a grassroots organization fighting for LGBTQ+ rights